维普期刊资源整合服务平台（V6.5）

268篇 您的检索式：作者名="Pea M"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	Renal pathology in the tuberous sclerosis complex显示文摘	Martignoni G Pea M Rocca P C	2003	Pathology2003，35，6：	1
2	Mineral/leucosome trace-element partitioning in a peraluminous migmatite (a laser ablation-ICP-MS study) 显示文摘	Pea F Pereira M Stroh A	1994	Chemical Geology1994，117，14：	1
3	Chrysanthemum chlorotic mottle viroid RNA:dissection of the pathogenicity determinant and comparative fitness of symptomatic and non-symptomatic variants显示文摘	Flores R	2002	J Mol Biol2002，321，：	1
4	Hyperlactacidemia potentially due to linezolid overexposure in a liver transplant recipient显示文摘	Pea F Scudeller L Lugano M	2006	Clin Infect Dis2006，42，3：	1
5	Issues in pharmacokinetics and pharmacodynamics of anti-infective agents:distribution in tissue显示文摘	Müller M dela Pea A Derendorf H	2004	Antimicrob Agents Chemother2004，48，：	1
6	PEComas: the past, the present and the future显示文摘	Martignoni G Pea M Reghellin D	2008	Virchows Arch2008，452，2：	1
7	Pharmacokinetics of two oral cyclosporine A formulations in clinically stable heart-transplant patients显示文摘	BARALDO M PEA F POZ D	2001	Pharmacol Res2001，43，6：	1
8	Antimicrobial therapy in critically ill patients : a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability显示文摘	Pea F Viale P Furlanut M	2005	Clin Pharmacokinet2005，44，10：	1
9	Peripheral regions of natural hammerhead ribozymes greatly increase their self-cleavage activity显示文摘	Gago S Flores R	2003	EMBO J2003，22，：	1
10	PEComas:the past,the present and the future显示文摘	MARTIGNONI G PEA M RGHELLEIN D	2008	Virchows Arch2008，52，4：	1
11	High vanco-mycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures显示文摘	PEA F PORRECA L BARALDO M	2000	J Antimicrob Chemother2000，45，3：	1
12	The perivascular epithe- lioid cell and related lesions 显示文摘	Bonetti F Pea M Martignoni G	1977	Adv Anat Pathol1977，4，6：	1
13	Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability 显示文摘	PEA F VIALE P FURLANUT M	2005	Clin Pharmacokinet2005，44，10：	1
14	Cellular heterogeneity in lymphangiomyomatesis of the lung显示文摘	Bonetti F Pea M Martisnoni G	1991	Hum Pathol1991，22，7：	1
15	Carcinoma -like monotypic hepatic angiomyolipoma in patients without evidence of tuberous sclerosis:a clinicopathologic and genetic study显示文摘	Martignoni G Pea M Bonetti F	1998	Am J Surg Pathol1998，22，：	1
16	Cathepsin-K immunoreactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas显示文摘	Martignoni G Pea M Gobbo S	2009	Mod Pathol2009，22，8：	1
17	Cathepsin-K expression in pulmonary lymphangioleiomyomatosis显示文摘	Chilosi M Pea M Martignoni G	2009	Mod Pathol2009，22，2：	1
18	PEComas:the past,the present and the future显示文摘	Martignoni G Pea M Reghellin D	2008	Virchows Archiv2008，452，：	1
19	Cathepsin - k immunore- activity distinguishes miff/tfe family renal translocation carcino- mas from other renal carcinomas 显示文摘	Martignoni G Pea M Gobbo S	2009	Mod Pathol2009，22，8：	1
20	Antimierobial agents in elective surgery : prophylaxis or 'early therapy'? 显示文摘	Pea F Viale P Furlanut M	2003	J Chemother2003，15，1：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示